Literature reviews  >  Articles for review > Marrazzo et al Predicting chlamydial... 

 

About SDI
Mission
Diagnostic
Priorities
Workplan
Activities
Newsletters
Grants
Publications
Journal articles
Guidelines
Manuals
Reports
Literature reviews
Contact us

Cervical findings suggesting chlamydial or gonococcal infection have higher positive predictive values in women less than 25 years old.

Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis.
Marrazzo JM, Handsfield HH, Whittington WLH.
Obstet Gynecol. 2002;100:579-84

 

Summary:

Question
How well do age, clinical signs of cervical infection, and inflammation on endocervical Gram stain predict infection with C. trachomatis and N. gonorrhoeae among women diagnosed by culture?

Design
This paper describes a retrospective study of women attending an STD clinic. All women had endocervical Gram stains and cultures for C. trachomatis and N. gonorrhoeae performed. Predictive values of age, cervical signs, and inflammation on Gram stain for the presence of C. trachomatis or N. gonorrhoeae by culture were calculated.

Participants
Records for 6230 new problem visits to Public Health, Seattle and King County STD Clinic by women who underwent pelvic examination, did not have signs of pelvic inflammatory disease, and were tested for C. trachomatis and N. gonorrhoeae were included in the analysis. Of these 6230 women, 430 (6.9%) had C. trachomatis and 133 (2.1%) had N. gonorrhoeae detected by culture.

Description of Tests and Diagnostic Standard
Clinicians performed Gram stain smears of endocervical secretions and quantified polymorphonuclear cells per 1000X field (PMN/HPF) by averaging the PMN number in each of at least 10 fields. Inflammation was defined as >30 PMN/HPF on Gram stain of endocervical secretions. Mucopurulent cervicitis was defined as the presence of either clinical sign (mucopus or easily induced bleeding at the cervix) and of cervical inflammation on Gram stain. C. trachomatis and N gonorrhoeae were identified by endocervical cultures according to standard methods.

Main Outcome Measures
The positive predictive values (PPV) and confidence intervals (CI) by age of the presence of either clinical sign, of cervical inflammation, and of mucopurulent cervicitis for cervical chlamydial or gonococcal infection as determined by culture were calculated.

Main Results
The PPVs of features associated with cervical chlamydial or gonococcal infection by age group are presented in the table. The PPV of all cervical findings and of Gram stain smear of endocervical secretions for cervical infection were significantly higher in women younger than 25 years than in women 25 years or older.

Inflammation on endocervical Gram stain was relatively insensitive in detecting infection in women without either cervical sign (sensitivity 26.5%, seen in 79 of 308 infections), and, among all 520 infected women, provided the only indication of chlamydial or gonococcal infection in 79 (15.2%).

Positive predictive values of features associated with cervical chlamydial or gonococcal infection by age group
Feature Num≤ber infected/Number with characteristic, PPV, 
and (95% CI)
≤19 y 20-24 y 25-29 y 30-44 y ≥45 y Total
Bleeding or mucopus 51/158
39%
(31, 47)
80/294
27%
(22, 33)
26/232
11%
(7.6, 16)
28/293
9.6%
(6.6, 14)
2/51
3.9%
(0.7, 15)
227/1028
20%
(17, 22)
≥30 PMN/HPF alone 63/175
36%
(29, 44)
80/307
26%
(21, 31)
36/210
17%
(12, 23)
28/227
12%
(8.5, 18)
2/40
5.0%
(0.9, 18)
209/959
22%
(19, 25)
Muco-purulent
cervicitis
33/81
41%
(30, 52)
57/151
38%
(30, 46)
20/100
20%
(13, 29)
15/102
15%
(8.7, 23)
2/21
9.5%
(1.7, 32)
127/455
28%
(24, 32)

Authors' Conclusions
The data support empiric treatment along with diagnostic testing for chlamydial or gonococcal cervical infections in women younger than 25 years in whom induced bleeding or cervical mucopus are detected, and only diagnostic testing for women 25 years and older. The performance of Gram stain smear of endocervical secretions in predicting chlamydial or gonococcal cervical infection does not justify its routine use.

Source of funding: In part by National Institutes of Health grant R29-AI41153-04

For correspondence: Jeanne M. Marrazzo, Harborview Medical Center, Box #359931, 325 Ninth Avenue, Seattle, WA 98104. E-mail address: jmm2@u.washington.edu

   

about SDI | newsletters | grants | publications | literature reviews

WHO Home - WHO Search - TDR Home - SDI Home - SDI Contact us
(c) WHO/OMS 2001